Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

516
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
516
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

397
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
397
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

441
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
441

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Eye and the Brain: Photonic Devices in Neuro-Ophthalmology.

Diseases (Basel, Switzerland)·2026
Same author

Claudio Bordignon.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers.

Pathology oncology research : POR·2026
Same author

Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.

Med (New York, N.Y.)·2026
Same author

Special Issue "Integrated Approaches, Molecular Mechanisms and Therapies in Ocular Surface Diseases".

International journal of molecular sciences·2026
Same author

Visual and Patient-Reported Outcomes After Bilateral Implantation of Two Enhanced Monofocal IOLs.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jun 9, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K

Artificial Intelligence and Advanced Technology in Glaucoma: A Review.

Emanuele Tonti1, Sofia Tonti2, Flavia Mancini3

  • 1UOC Ophthalmology, Sant'Eugenio Hospital, 00144 Rome, Italy.

Journal of Personalized Medicine
|October 25, 2024
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) enhances personalized glaucoma care through early detection, diagnosis, and treatment optimization. AI tools improve patient outcomes by integrating predictive analytics and enabling remote monitoring for better clinical decisions.

Keywords:
artificial intelligencedeep learningglaucomamachine learningocular hypertensionpersonalized medicine

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K

Related Experiment Videos

Last Updated: Jun 9, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.4K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K

Area of Science:

  • Ophthalmology
  • Medical Informatics
  • Artificial Intelligence

Background:

  • Glaucoma is a primary cause of irreversible blindness globally, requiring individualized management.
  • Artificial intelligence (AI) offers transformative potential for personalized glaucoma care.

Purpose of the Study:

  • To review AI applications in personalized glaucoma patient management.
  • To highlight advancements, challenges, and future directions in this field.

Main Methods:

  • Systematic literature search of PubMed, Scopus, and Web of Science up to 2024.
  • Inclusion of studies on AI techniques for personalized glaucoma management.

Main Results:

  • AI, especially deep learning, accurately diagnoses glaucoma from OCT and visual field tests.
  • AI risk stratification tools personalize treatment, improving outcomes and minimizing side effects.
  • AI-powered teleophthalmology enhances remote monitoring and patient access to care.

Conclusions:

  • AI integration in glaucoma management optimizes clinical decisions and treatment efficacy.
  • Challenges include data heterogeneity, model interpretability, and regulatory issues.
  • Future research needs algorithm refinement, clinical validation, and seamless integration into practice.